PKY.AU Pathkey.ai Ltd

Healthcare Health Information Services Australian Securities Exchange
0.0160 AUD
Close of Oct 28, 2026
0.0132 0.0750
Market cap
AUD 21.6M
P/E
-
P/B
0.54x
ROE
-9.2%
Dividend yield
-
Fundamental score
1.3/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is PKY.AU undervalued?

Graham number

The Graham number of Pathkey.ai Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pathkey.ai Ltd fundamental analysis

6 of 21 checks passed

ROE 0/2

Low return on equity (-9.2%), below 10%.

ROA 1/1

Return on assets (-9.1%) is above the industry median (-82.9%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-16.0%) is below the industry median (-16.0%).

Revenue Growth 0/2

Revenue shrank 50.7% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Cash Runway 2/2

Cash covers 3.3 years of the current cash burn.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (0.5x) is below the industry median (1.8x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Pathkey.ai Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pathkey.ai Ltd

Pathkey.AI Ltd, a technology company, develops agentic AI solutions in Australia. The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.

Full company profile